Skip to main content
Erschienen in:

03.08.2020 | 2020 SAGES Oral

Impact of bariatric surgery on the development of diabetic microvascular and macrovascular complications

verfasst von: Iliya Goldberg, Lizhou Nie, Jie Yang, Salvatore Docimo, Silvana Obici, Mark Talamini, Aurora Pryor, Konstantinos Spaniolas

Erschienen in: Surgical Endoscopy | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

While bariatric surgery has been shown to improve type 2 diabetes (DM) control in the obese population, the effect on long-term DM complications has been less thoroughly investigated. The purpose of this study was to assess the development of microvascular and macrovascular complications in obese DM patients undergoing bariatric surgery.

Methods

New York patients’ records from the SPARCS database in years 2006–2012 were used to identify obese patients with DM. Patients undergoing bariatric surgery were compared with patients managed medically, matched for age and gender. Patients were grouped based on baseline presence of controlled or uncontrolled DM and followed over time for the development of micro- and macrovascular complications. Cumulative incidence of complications was estimated with death treated as a competing risk event. Multivariable proportional sub-distribution hazards models were used to compare the risk of complications among different patient groups after adjusting for possible confounding factors.

Results

A total of 88,981 patients were reviewed, including 15,585 (18%) that were treated with bariatric surgery. Surgery patients had significantly lower risk of microvascular complications compared to non-surgery patients (controlled diabetes: HR = 0.40, 95% CI 0.37–0.42; uncontrolled diabetes: HR = 0.51, 95% CI 0.37–0.71). Similarly, the surgical patients were noted to have a significantly lower risk for macrovascular complications compared to non-surgery patients (controlled diabetes: HR = 0.43, 95% CI 0.40–0.46; uncontrolled diabetes: HR = 0.44, 95% CI 0.28–0.69). Cumulative incidence of microvascular complications was lower at 1, 5 and 9 years for the surgical groups for controlled and uncontrolled DM. Similar trends were observed for the macrovascular complications.

Conclusions

Bariatric surgery appears to prevent complications of DM. Bariatric surgery patients with DM experienced significantly lower rates of microvascular and macrovascular complications, compared to non-surgically treated comparison group. Bariatric surgery was noted to offer protective benefits for both complicated and non-complicated DM patients. This reduced rate of complications was sustained in the long term.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wild S et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053CrossRef Wild S et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053CrossRef
2.
Zurück zum Zitat Hofso D et al (2019) Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol 7(12):912–924CrossRef Hofso D et al (2019) Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol 7(12):912–924CrossRef
3.
Zurück zum Zitat Grams J, Garvey WT (2015) Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 4(2):287–302CrossRef Grams J, Garvey WT (2015) Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 4(2):287–302CrossRef
4.
Zurück zum Zitat Dyck PJ et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43(4):817–824CrossRef Dyck PJ et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43(4):817–824CrossRef
5.
Zurück zum Zitat Adams TD et al (2016) Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care 39(6):912–923CrossRef Adams TD et al (2016) Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care 39(6):912–923CrossRef
6.
Zurück zum Zitat Sjostrom L et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311(22):2297–2304CrossRef Sjostrom L et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311(22):2297–2304CrossRef
7.
Zurück zum Zitat Yip S, Plank LD, Murphy R (2013) Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg 23(12):1994–2003CrossRef Yip S, Plank LD, Murphy R (2013) Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg 23(12):1994–2003CrossRef
8.
Zurück zum Zitat Ricci C et al (2015) Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg 25(3):397–405CrossRef Ricci C et al (2015) Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg 25(3):397–405CrossRef
9.
Zurück zum Zitat Wu GZ et al (2016) Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget 7(52):87511–87522CrossRef Wu GZ et al (2016) Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget 7(52):87511–87522CrossRef
10.
Zurück zum Zitat Coleman KJ et al (2016) Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care 39(8):1400–1407CrossRef Coleman KJ et al (2016) Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care 39(8):1400–1407CrossRef
11.
Zurück zum Zitat Sheng B et al (2017) The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg 27(10):2724–2732CrossRef Sheng B et al (2017) The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg 27(10):2724–2732CrossRef
12.
Zurück zum Zitat Aminian A et al (2019) Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA 322(13):1271–1282CrossRef Aminian A et al (2019) Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA 322(13):1271–1282CrossRef
13.
Zurück zum Zitat Tandon N, Ali MK, Narayan KM (2012) Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs 12(1):7–22CrossRef Tandon N, Ali MK, Narayan KM (2012) Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs 12(1):7–22CrossRef
14.
Zurück zum Zitat Mingrone G et al (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386(9997):964–973CrossRef Mingrone G et al (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386(9997):964–973CrossRef
15.
Zurück zum Zitat Schauer PR et al (2017) Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 376(7):641–651CrossRef Schauer PR et al (2017) Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 376(7):641–651CrossRef
16.
Zurück zum Zitat Romeo S et al (2012) Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 35(12):2613–2617CrossRef Romeo S et al (2012) Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 35(12):2613–2617CrossRef
17.
Zurück zum Zitat Chen Y et al (2016) Gastric bypass surgery leads to long-term remission or improvement of type 2 diabetes and significant decrease of microvascular and macrovascular complications. Ann Surg 263(6):1138–1142CrossRef Chen Y et al (2016) Gastric bypass surgery leads to long-term remission or improvement of type 2 diabetes and significant decrease of microvascular and macrovascular complications. Ann Surg 263(6):1138–1142CrossRef
18.
Zurück zum Zitat Miras AD et al (2019) Metabolic changes and diabetes microvascular complications 5 years after obesity surgery. Obes Surg 29(12):3907–3911CrossRef Miras AD et al (2019) Metabolic changes and diabetes microvascular complications 5 years after obesity surgery. Obes Surg 29(12):3907–3911CrossRef
19.
Zurück zum Zitat Kristensson FM et al (2020) Effects of Bariatric Surgery in Early- and Adult-Onset Obesity in the Prospective Controlled Swedish Obese Subjects Study. Diabetes Care 43(4):860–866CrossRef Kristensson FM et al (2020) Effects of Bariatric Surgery in Early- and Adult-Onset Obesity in the Prospective Controlled Swedish Obese Subjects Study. Diabetes Care 43(4):860–866CrossRef
20.
Zurück zum Zitat Carlsson LMS et al (2017) Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 5(4):271–279CrossRef Carlsson LMS et al (2017) Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 5(4):271–279CrossRef
Metadaten
Titel
Impact of bariatric surgery on the development of diabetic microvascular and macrovascular complications
verfasst von
Iliya Goldberg
Lizhou Nie
Jie Yang
Salvatore Docimo
Silvana Obici
Mark Talamini
Aurora Pryor
Konstantinos Spaniolas
Publikationsdatum
03.08.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 7/2021
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-020-07848-2

Neu im Fachgebiet Chirurgie

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Soll man bei Cholezystektomie routinemäßig cholangiografieren?

Eine US-Studie scheint den Befürwortern einer routinemäßigen intraoperativen Cholangiografie im Rahmen einer Cholezystektomie Recht zu geben. Die Studienkommentatoren in JAMA Surgery sparen jedoch nicht mit Kritik.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.